Abstract
Exposure to pesticides is implicated in the etiopathogenesis of Parkinson's disease (PD). The organochlorine pesticide dieldrin is one of the environmental chemicals potentially linked to PD. Because recent evidence indicates that abnormal accumulation and aggregation of α-synuclein and ubiquitin-proteasome system dysfunction can contribute to the degenerative processes of PD, in the present study we examined whether the environmental pesticide dieldrin impairs proteasomal function and subsequently promotes apoptotic cell death in rat mesencephalic dopaminergic neuronal cells overexpressing human α-synuclein. Overexpression of wild-type α-synuclein significantly reduced the proteasomal activity. Dieldrin exposure dose-dependently (0–70 μM) decreased proteasomal activity, and 30 μM dieldrin inhibited activity by more than 60% in α-synuclein cells. Confocal microscopic analysis of dieldrin-treated α-synuclein cells revealed that α-synuclein-positive protein aggregates colocalized with ubiquitin protein. Further characterization of the aggregates with the autophagosomal marker mondansyl cadaverine and the lysosomal marker and dot-blot analysis revealed that these protein oligomeric aggregates were distinct from autophagosomes and lysosomes. The dieldrin-induced proteasomal dysfunction in α-synuclein cells was also confirmed by significant accumulation of ubiquitin protein conjugates in the detergent-insoluble fraction. We found that proteasomal inhibition preceded cell death after dieldrin treatment and that α-synuclein cells were more sensitive than vector cells to the toxicity. Furthermore, measurement of caspase-3 and DNA fragmentation confirmed the enhanced sensitivity of α-synuclein cells to dieldrin-induced apoptosis. Together, our results suggest that increased expression of α-synuclein predisposes dopaminergic cells to proteasomal dysfunction, which can be further exacerbated by environmental exposure to certain neurotoxic compounds, such as dieldrin.
Footnotes
-
This study was supported by National Institutes of Health Grants NS45133, ES10586, and NS38644.
-
doi:10.1124/jpet.105.084632.
-
ABBREVIATIONS: PD, Parkinson's disease; MDC, monodansyl cadaverine; AMC, 7-amino-4-methylcoumarin; ECL, enhanced chemiluminescence; ELISA, enzyme-linked immunosorbent assay; PBS, phosphate-buffered saline; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid; LAMP-1, lysosomal associated membrane protein 1; HRP, horseradish peroxidase; ANOVA, analysis of variance; UPS, ubiquitin proteasome system; HMW, high molecular weight; Trolox, 6-hydroxy-2,5,7,8-tetramethyl-chroman-2-carboxylic acid; Suc, N-succinyl.
- Received February 5, 2005.
- Accepted June 27, 2005.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|